Drug intelligence / Profile preview

Flurandrenolide acetate

Development stage
Approved
Lead developer
Almirall
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Flurandrenolide acetate is a synthetic fluorinated corticosteroid primarily used topically to alleviate inflammatory and pruritic manifestations of various corticosteroid-responsive dermatoses. Its therapeutic action stems from its ability to bind to specific cytoplasmic glucocorticoid receptors within target cells. This binding initiates a cascade of events, including the translocation of the receptor-drug complex into the cell nucleus, where it modulates gene expression. This leads to anti-inflammatory effects by stabilizing cellular and lysosomal membranes, inhibiting phospholipase A2, and consequently reducing the biosynthesis of prostaglandins and leukotrienes. Additionally, it exhibits antipruritic effects by stabilizing mast cells and vasoconstrictive properties, which help reduce erythema and edema in inflamed tissues. It is available in various topical formulations such as creams, ointments, lotions, and tapes, with varying potencies depending on the formulation.

Brand names
CordranCordran SPCordran TapeNolixHaelanDrenisonDrocortSermakaHaldrone-FAlondra-F
Other names
FludroxycortideFlurandrenoloneFluorandrenoloneFludroxicortidaFludroxycortidum
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Flurandrenolide acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flurandrenolide acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call